Zhittya Logo.jpg
Zhittya Genesis Medicine-Parkinson’s Disease-Free Webinar for its Clinical Trial to treat Parkinson’s Disease
January 26, 2022 10:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of...
Zhittya Logo.jpg
Zhittya Genesis Medicine Starts ALS/Motor Neuron Disease Clinical Trial
January 18, 2022 11:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for the treatment of...
Zhittya Logo.jpg
Zhittya Genesis Medicine Starts Parkinson’s Disease Clinical Trial
January 12, 2022 11:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of...
Zhittya Logo.jpg
Mr. Daniel C. Montano, CEO, is recognized as Biotech Entrepreneur of the Year and Dr. Marc Kahn as Medical Professional of the Year by the Nevada Biotechnology & Health Science Consortium
June 17, 2021 13:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, June 17, 2021 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), is proud to announce that Mr. Daniel C. Montano, CEO, and founder of...
Zhittya Logo.jpg
Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?
November 18, 2020 00:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...
Zhittya Logo.jpg
Zhittya Genesis Medicine Announces It Has Been Approved to Initiate Clinical Trials in Mexico for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
October 15, 2020 10:30 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials in Mexico to test a medical hypothesis that...
Zhittya Logo.jpg
Zhittya Genesis Medicine Announces a Potential Major Medical Breakthrough for the Treatment of Parkinson’s Disease
September 22, 2020 10:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials to test a medical hypothesis that has been...
Zhittya Logo.jpg
Zhittya Genesis Medicine, Inc. Announces a Zoom Webinar
July 22, 2020 10:30 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, July 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Zoom Webinar on its potential breakthrough therapy to reverse...
Zhittya Logo.jpg
COVID-19 Lung Damage: Potential Breakthrough Drug Treatment Disclosed by Zhittya Genesis Medicine in Their Newly Released White Paper
June 17, 2020 10:30 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company)(“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...
Zhittya Logo.jpg
Zhittya Genesis Medicine Releases Latest White Paper Highlighting its Potential Breakthrough Drug Treatment for Chronic Depression
February 19, 2020 12:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...